Discovery of Q‐Markers of Mudan Granules by Chemical Profile, Pharmacokinetics, Neuroprotective Effect Evaluation, and Network Pharmacology
Biomedical Chromatography · 2026-07 · 40 (7)
DOI: 10.1002/bmc.70494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 26.05.2026. Verfasst von Zhiyan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Neuroprotective Agents. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jinhua Science and Technology Program.
Abstract (Originalsprache)
Mudan granules (MDs) are a widely used Chinese patent medicine for treating diabetic peripheral neuropathy (DPN). TCM quality is the basis to ensure its efficacy; however, the current quality standard for MD relies on the control of only two constituents derived from the minister drugs. Therefore, it is necessary to establish a more comprehensive quality evaluation system based on rational quality markers (Q‐markers). In this study, Q‐markers of MD were discovered through systematic evaluations. Thirty‐seven compounds were newly characterized in MD by UPLC‐QTOF‐MS. Among all the 173 constituents in MD, 64 were found to be absorbed into the bloodstream and/or sciatic nerve of rats in prototype. The contents of 24 candidate Q‐markers were determined, and the pharmacokinetics features of nine ones were analyzed by two developed UPLC‐MS methods. Six candidate Q‐markers were first found to exhibit protective effects on Schwann cells against the injury of high glucose/lipid. Finally, nine Q‐markers were screened, and network pharmacology analysis showed that the enriched pathways for these nine Q‐markers covered the major DPN‐related pathways for the full set of 173 constituents. The results provide important evidence for improving the quality control system of MD and reference for discovering Q‐markers of other TCM prescriptions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- Innovation Center of Translational Pharmacy, Jinhua Institute of Zhejiang University, Jinhua, China.
Förderung
- National Natural Science Foundation of China
- Jinhua Science and Technology Program
Zitieren
APA
Wang, Z., Zhang, S., Hu, C., & Wang, S. (2026). Discovery of Q‐Markers of Mudan Granules by Chemical Profile, Pharmacokinetics, Neuroprotective Effect Evaluation, and Network Pharmacology. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70494
Vancouver
Wang Z, Zhang S, Hu C, Wang S. Discovery of Q‐Markers of Mudan Granules by Chemical Profile, Pharmacokinetics, Neuroprotective Effect Evaluation, and Network Pharmacology. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70494
BibTeX
@article{Wang2026,
author = {Wang, Zhiyan and Zhang, Shiqi and Hu, Chenxiu and Wang, Shufang},
title = {Discovery of Q‐Markers of Mudan Granules by Chemical Profile, Pharmacokinetics, Neuroprotective Effect Evaluation, and Network Pharmacology},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {7},
doi = {10.1002/bmc.70494}
}
EUVIMED